{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:15:01Z","timestamp":1787498101993,"version":"build-2736575974"},"reference-count":46,"publisher":"American Diabetes Association","issue":"6","license":[{"start":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T00:00:00Z","timestamp":1630022400000},"content-version":"vor","delay-in-days":3392,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6,1]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Hypoglycemia and exercise both induce the release of \u03b2-endorphin, which plays an important role in the modulation of the autonomic response during subsequent events. Because opioid receptor (OR) blockade during antecedent hypoglycemia has been shown to prevent hypoglycemia-associated autonomic failure, we hypothesized that OR blockade during exercise would prevent exercise-associated autonomic failure (EAAF). We studied 8 healthy subjects on 2 consecutive days, each of whom participated in three different studies in random order. The protocol on day 1 involved one of the following: 1) two 90-min hyperinsulinemic-euglycemic clamps plus naloxone infusion (control); 2) two 90-min hyperinsulinemic-euglycemic clamps with exercise at 60% Vo2max, plus naloxone infusion (N+); or 3) same protocol as in the N+ group, but with saline infusion only (N\u2212). On day 2, all were studied with stepped hyperinsulinemic-hypoglycemic clamps, using hormone concentrations and glucose turnover as indicators of hypoglycemia counterregulation. Compared with control, N\u2212 studies resulted in significantly blunted epinephrine and norepinephrine responses to subsequent hypoglycemia. Conversely, the N+ group exhibited unimpaired hypoglycemia counterregulation, characterized by appropriate increases in epinephrine, norepinephrine, and endogenous glucose production. Thus, OR blockade with naloxone during antecedent exercise prevents the development of acute EAAF by improving the catecholamine responses and by restoring endogenous glucose production.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/db11-1622","type":"journal-article","created":{"date-parts":[[2012,4,21]],"date-time":"2012-04-21T02:44:46Z","timestamp":1334976286000},"page":"1609-1615","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":13,"title":["Opioid Receptor Blockade Prevents Exercise-Associated Autonomic Failure in Humans"],"prefix":"10.2337","volume":"61","author":[{"given":"Sofiya","family":"Milman","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Leu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Shamoon","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, New York"},{"name":"Institute for Clinical and Translational Research, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Septimiu","family":"Vele","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Gabriely","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, Albert Einstein College of Medicine, Bronx, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2012,5,14]]},"reference":[{"key":"2022031210550022500_B1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes\u20142011","volume":"34","author":"American Diabetes Association","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031210550022500_B2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"The Diabetes Control and Complications Trial Research Group","year":"1993","journal-title":"N Engl J Med"},{"key":"2022031210550022500_B3","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9343(91)90605-W","article-title":"Epidemiology of severe hypoglycemia in the diabetes control and complications trial","volume":"90","author":"The DCCT Research Group","year":"1991","journal-title":"Am J Med"},{"key":"2022031210550022500_B4","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.2337\/db08-1084","article-title":"The barrier of hypoglycemia in diabetes","volume":"57","author":"Cryer","year":"2008","journal-title":"Diabetes"},{"key":"2022031210550022500_B5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1172\/JCI116302","article-title":"Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia","volume":"91","author":"Dagogo-Jack","year":"1993","journal-title":"J Clin Invest"},{"key":"2022031210550022500_B6","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.2337\/diabetes.54.12.3592","article-title":"Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes","volume":"54","author":"Cryer","year":"2005","journal-title":"Diabetes"},{"key":"2022031210550022500_B7","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/dmrr.450","article-title":"Evidence for a vicious cycle of exercise and hypoglycemia in type 1 diabetes mellitus","volume":"20","author":"Ertl","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"2022031210550022500_B8","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.2337\/dc08-0720","article-title":"Barriers to physical activity among patients with type 1 diabetes","volume":"31","author":"Brazeau","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031210550022500_B9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jpeds.2005.04.065","article-title":"Impact of exercise on overnight glycemic control in children with type 1 diabetes mellitus","volume":"147","author":"Tsalikian","year":"2005","journal-title":"J Pediatr"},{"key":"2022031210550022500_B10","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/diabetes.53.7.1798","article-title":"Effects of low and moderate antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes","volume":"53","author":"Sandoval","year":"2004","journal-title":"Diabetes"},{"key":"2022031210550022500_B11","doi-asserted-by":"crossref","first-page":"E1331","DOI":"10.1152\/ajpendo.00283.2005","article-title":"Acute, same-day effects of antecedent exercise on counterregulatory responses to subsequent hypoglycemia in type 1 diabetes mellitus","volume":"290","author":"Sandoval","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210550022500_B12","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1210\/jc.2009-0882","article-title":"Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade","volume":"94","author":"Leu","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210550022500_B13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.2010.05820.x","article-title":"Neuroendocrine responses to hypoglycemia","volume":"1212","author":"Tesfaye","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"2022031210550022500_B14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2165\/00007256-199724010-00002","article-title":"Beta-endorphin response to exercise. An update","volume":"24","author":"Goldfarb","year":"1997","journal-title":"Sports Med"},{"key":"2022031210550022500_B15","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1210\/jcem-49-6-838","article-title":"Substantial rise of plasma beta-endorphin levels after insulin-induced hypoglycemia in human subjects","volume":"49","author":"Nakao","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031210550022500_B16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0002-8703(73)90502-4","article-title":"Maximal oxygen intake and nomographic assessment of functional aerobic impairment in cardiovascular disease","volume":"85","author":"Bruce","year":"1973","journal-title":"Am Heart J"},{"key":"2022031210550022500_B17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000174177","article-title":"Cardiopulmonary exercise testing in clinical practice","volume":"74","author":"Weber","year":"1987","journal-title":"Cardiology"},{"key":"2022031210550022500_B18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2337\/diab.36.8.914","article-title":"Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps. Comparison of unlabeled and labeled exogenous glucose infusates","volume":"36","author":"Finegood","year":"1987","journal-title":"Diabetes"},{"key":"2022031210550022500_B19","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1152\/ajplegacy.1976.230.4.1159","article-title":"Estimation of glucose turnover and recycling in rabbits using various [3H, 14C]glucose labels","volume":"230","author":"Dunn","year":"1976","journal-title":"Am J Physiol"},{"key":"2022031210550022500_B20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2337\/diacare.17.3.183","article-title":"Effect of antecedent hypoglycemia on cognitive function and on glycemic thresholds for counterregulatory hormone secretion in healthy humans","volume":"17","author":"Mellman","year":"1994","journal-title":"Diabetes Care"},{"key":"2022031210550022500_B21","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1749-6632.1959.tb44923.x","article-title":"Influences of glucose loading and of injected insulin on hepatic glucose output","volume":"82","author":"Steele","year":"1959","journal-title":"Ann N Y Acad Sci"},{"key":"2022031210550022500_B22","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1152\/ajpendo.2001.280.6.E908","article-title":"Effects of antecedent prolonged exercise on subsequent counterregulatory responses to hypoglycemia","volume":"280","author":"Galassetti","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031210550022500_B23","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.2337\/diabetes.51.5.1485","article-title":"Limited impact of vigorous exercise on defenses against hypoglycemia: relevance to hypoglycemia-associated autonomic failure","volume":"51","author":"McGregor","year":"2002","journal-title":"Diabetes"},{"key":"2022031210550022500_B24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00238563","article-title":"Endogenous opioids may modulate catecholamine secretion during high intensity exercise","volume":"70","author":"Angelopoulos","year":"1995","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"2022031210550022500_B25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1152\/jappl.1994.76.6.2452","article-title":"Opioid antagonism alters blood glucose homeostasis during exercise in humans","volume":"76","author":"Hickey","year":"1994","journal-title":"J Appl Physiol"},{"key":"2022031210550022500_B26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2337\/diab.43.6.809","article-title":"Hypoglycemia-induced autonomic failure in IDDM is specific for stimulus of hypoglycemia and is not attributable to prior autonomic activation","volume":"43","author":"Rattarasarn","year":"1994","journal-title":"Diabetes"},{"key":"2022031210550022500_B27","doi-asserted-by":"crossref","first-page":"S271","DOI":"10.2337\/diabetes.51.2007.S271","article-title":"Intense exercise has unique effects on both insulin release and its roles in glucoregulation: implications for diabetes","volume":"51","author":"Marliss","year":"2002","journal-title":"Diabetes"},{"key":"2022031210550022500_B28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s004210100501","article-title":"Beta-endorphin immunoreactivity during high-intensity exercise with and without opiate blockade","volume":"86","author":"Angelopoulos","year":"2001","journal-title":"Eur J Appl Physiol"},{"key":"2022031210550022500_B29","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1007\/s00018-010-0414-7","article-title":"Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis","volume":"67","author":"Jordan","year":"2010","journal-title":"Cell Mol Life Sci"},{"key":"2022031210550022500_B30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF00834417","article-title":"Detection of the pro-opiomelanocortin peptide fragments\u2014beta-endorphin and ACTH\u2014in the adrenals of rats and mice by immunohistochemistry.","volume":"101","author":"Arefolov","year":"1986","journal-title":"Biull Eksp Biol Med"},{"key":"2022031210550022500_B31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1566-0702(01)00321-6","article-title":"Stimulatory effect of phenylephrine on the secretion of beta-endorphin from rat adrenal medulla in vitro","volume":"93","author":"Cheng","year":"2001","journal-title":"Auton Neurosci"},{"key":"2022031210550022500_B32","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI119165","article-title":"Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats","volume":"99","author":"Borg","year":"1997","journal-title":"J Clin Invest"},{"key":"2022031210550022500_B33","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1172\/JCI117150","article-title":"Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia","volume":"93","author":"Borg","year":"1994","journal-title":"J Clin Invest"},{"key":"2022031210550022500_B34","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2337\/diab.44.2.180","article-title":"Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release","volume":"44","author":"Borg","year":"1995","journal-title":"Diabetes"},{"key":"2022031210550022500_B35","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0006-8993(90)90015-4","article-title":"Distribution of mu, delta, and kappa opioid receptors in the hypothalamus of the rat","volume":"536","author":"Desjardins","year":"1990","journal-title":"Brain Res"},{"key":"2022031210550022500_B36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1469-7793.1999.0431t.x","article-title":"Pre- and postsynaptic actions of opioid and orphan opioid agonists in the rat arcuate nucleus and ventromedial hypothalamus in vitro","volume":"517","author":"Emmerson","year":"1999","journal-title":"J Physiol"},{"key":"2022031210550022500_B37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-2999(96)00293-2","article-title":"Functional analysis of opioid receptor subtypes in the ventromedial hypothalamic nucleus of the rat","volume":"308","author":"Zhang","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"2022031210550022500_B38","first-page":"1325","article-title":"Beta-endorphin inhibits hypoglycemia-induced gene expression of corticotropin-releasing factor in the rat hypothalamus","volume":"130","author":"Suda","year":"1992","journal-title":"Endocrinology"},{"key":"2022031210550022500_B39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/db10-0326","article-title":"Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of metabolic reprogramming in counterregulatory failure","volume":"60","author":"Poplawski","year":"2011","journal-title":"Diabetes"},{"key":"2022031210550022500_B40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ecam\/neh027","article-title":"Mediation of endogenous beta-endorphin by Tetrandrine to lower plasma glucose in streptozotocin-induced diabetic rats","volume":"1","author":"Hsu","year":"2004","journal-title":"Evid Based Complement Alternat Med"},{"key":"2022031210550022500_B41","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1124\/jpet.103.053900","article-title":"Mediation of beta-endorphin by isoferulic acid to lower plasma glucose in streptozotocin-induced diabetic rats","volume":"307","author":"Liu","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"2022031210550022500_B42","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1055\/s-2002-35418","article-title":"Plasma glucose-lowering effect of beta-endorphin in streptozotocin-induced diabetic rats","volume":"34","author":"Cheng","year":"2002","journal-title":"Horm Metab Res"},{"key":"2022031210550022500_B43","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/endo.142.5.8133","article-title":"Opioids suppress basal and nicotine-induced catecholamine secretion via a stabilizing effect on actin filaments","volume":"142","author":"Dermitzaki","year":"2001","journal-title":"Endocrinology"},{"key":"2022031210550022500_B44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0024-3205(95)02257-0","article-title":"Opioids inhibit dopamine secretion from PC12 rat pheochromocytoma cells in a naloxone-reversible manner","volume":"58","author":"Venihaki","year":"1996","journal-title":"Life Sci"},{"key":"2022031210550022500_B45","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2337\/db10-1374","article-title":"Adrenergic mediation of hypoglycemia-associated autonomic failure","volume":"60","author":"Ramanathan","year":"2011","journal-title":"Diabetes"},{"key":"2022031210550022500_B46","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0026-0495(96)90043-8","article-title":"Defective endogenous opioid response to exercise in type I diabetic patients","volume":"45","author":"Wanke","year":"1996","journal-title":"Metabolism"}],"container-title":["Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.org\/diabetes\/diabetes\/article-pdf\/61\/6\/1609\/562252\/1609.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article-pdf\/61\/6\/1609\/562252\/1609.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T12:29:26Z","timestamp":1667392166000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/diabetes\/article\/61\/6\/1609\/15330\/Opioid-Receptor-Blockade-Prevents-Exercise"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,14]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,5,14]]},"published-print":{"date-parts":[[2012,6,1]]}},"URL":"https:\/\/doi.org\/10.2337\/db11-1622","relation":{},"ISSN":["0012-1797","1939-327X"],"issn-type":[{"value":"0012-1797","type":"print"},{"value":"1939-327X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,14]]}}}